Monash IVF Group Limited (MNIVF)

Market Cap	222.15M +24.5%
Revenue (ttm)	186.41M -0.9%
Net Income	5.14M -70.3%
EPS	0.01 -70.3%
Shares Out	n/a
PE Ratio	43.25
Forward PE	16.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,000
Open	0.4000
Previous Close	0.5100
Day's Range	0.4000 - 0.4000
52-Week Range	0.4000 - 0.7400
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About Monash IVF Group

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 892
• Stock Exchange: OTCMKTS
• Ticker Symbol: MNIVF

Financial Performance

In fiscal year 2026, Monash IVF Group's revenue was 269.46 million, a decrease of -0.90% compared to the previous year's 271.92 million. Earnings were 7.43 million, a decrease of -70.31%.

Financial numbers in AUD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 11, 2026

Data Sources Report a data error